Company Filing History:
Years Active: 2001-2006
Title: Frank Petersen: Innovator in Cytostatics
Introduction
Frank Petersen is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of cytostatics, particularly through his innovative processes and formulations. With a total of 3 patents to his name, Petersen's work has had a meaningful impact on medical research and pharmaceutical development.
Latest Patents
Petersen's latest patents focus on a fermentative preparation process for and crystal forms of cytostatics. The inventions relate to a new process for concentrating epothilones in culture media, a new method for the production of epothilones, and a new process for separating epothilones A and B. Additionally, he has developed a new strain obtained by mutagenesis for the production of epothilones, along with new crystal forms of epothilone B.
Career Highlights
Frank Petersen is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to further his research and development efforts in the pharmaceutical industry. Petersen's innovative approaches have contributed to advancements in cancer treatment options.
Collaborations
Throughout his career, Petersen has collaborated with esteemed colleagues such as Hans Hofmann and Marion Mahnke. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Frank Petersen's contributions to the field of cytostatics exemplify the importance of innovation in medical research. His patents and collaborative efforts continue to influence the development of effective cancer treatments.